NEW YORK, Sept. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

http://www.reportlinker.com/p0848580/Immunochemistry-Analyzers-and-Test-...

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global immunochemistry market. The report provides market landscape, competitive landscape and market trends information on the immunochemistry market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Anemia/ Vitamin Tests, Disease Specific Immunochemistry, Drugs of Abuse/Toxicology, Therapeutic Drug Monitoring, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests, Organ Function Assays and Specific Proteins.

- Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018, and company shares data for 2011.

- Qualitative analysis of key market trends, market drivers, and restraints within clinical chemistry market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the immunochemistry globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify the key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.

- What's the next big thing in the immunochemistry market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global immunochemistry market and the factors shaping it.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 GlobalData Report Guidance 9

3 Immunochemistry Overview 10

3.1 Immunochemistry, Market Segmentation 10

3.1.1 Anemia/Vitamin Tests 11

3.1.2 Disease Specific Immunochemistry 11

3.1.3 Drugs of Abuse/Toxicology 13

3.1.4 Therapeutic Drug Monitoring (TDM) 14

3.1.5 Endocrinology Tests 15

3.1.6 Immunochemistry Analyzers 16

3.1.7 Immunochemistry Rapid Tests 16

3.1.8 Organ Function Assays 16

3.1.9 Specific Proteins 16

4 Immunochemistry - Global Market Characterization 17

4.1 Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011 17

4.2 Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018 18

4.3 Immunochemistry Market, Key Trends 19

4.3.1 Improvement in Software, Hardware Technology and User Interface to Improve Immunochemistry Analyzers Adoption Rate 19

4.3.2 Advent of Home Based Testing Methods to Lead to Increase in Demand for Diagnostic Testing 20

4.3.3 Point of Care Testing (POCT) to be in High Demand but Adoption will Depend on Technological Developments in this Field 21

4.4 Immunochemistry, Market Dynamics 22

4.4.1 Market Drivers 22

4.4.2 Market Restraints 31

5 Global Immunochemistry Market - Analysis by Segment 35

5.1 Anemia/ Vitamin Test Market, Global, Revenue ($m), Historic, 2004 - 2011 35

5.2 Anemia/ Vitamin Test Market, Global, Revenue ($m), Forecast, 2011 - 2018 36

5.3 Anemia/ Vitamin Test Market, Market Dynamics 37

5.3.1 Market Drivers 37

5.3.2 Market Restraint 40

5.4 Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2004 - 2011 41

5.5 Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2011 - 2018 42

5.6 Disease Specific Immunochemistry, Market Dynamics 43

5.6.1 Market Drivers 43

5.6.2 Market Restraints 49

5.7 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2004 - 2011 51

5.8 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2011 - 2018 52

5.9 Drugs of Abuse/Toxicology, Market Dynamics 53

5.9.1 Market Drivers 53

5.9.2 Market Restraints 57

5.10 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2004 - 2011 58

5.11 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2011 - 2018 59

5.12 Therapeutic Drug Monitoring, Market Dynamics 60

5.12.1 Market Driver 60

5.12.2 Market Restraint 60

5.13 Endocrinology Tests Market, Global, Revenue ($m), Historic, 2004 - 2011 62

5.14 Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2011 - 2018 63

5.15 Endocrinology Tests, Market Dynamics 64

5.15.1 Market Driver 64

5.15.2 Market Restraint 65

5.16 Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2004 - 2011 66

5.17 Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2011 - 2018 67

5.18 Immunochemistry Analyzers, Market Dynamics 68

5.18.1 Market Driver 68

5.18.2 Market Restraint 68

5.19 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2004-2011 69

5.20 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2011-2018 70

5.21 Immunochemistry Rapid Tests, Market Dynamics 71

5.21.1 Market Driver 71

5.21.2 Market Restraint 71

5.22 Organ Function Assays Market, Global, Revenue ($m), Historic, 2004-2011 72

5.23 Organ Function Assays Market, Global, Revenue ($m), Forecast, 2011-2018 73

5.24 Organ Function Assays, Market Dynamics 74

5.24.1 Market Driver 74

5.24.2 Market Restraint 74

5.25 Specific Proteins Market, Global, Revenue ($m), Historic, 2004-2011 75

5.26 Specific Proteins Market, Global, Revenue ($m), Forecast, 2011-2018 76

5.27 Specific Proteins, Market Dynamics 77

5.27.1 Market Driver 77

5.27.2 Market Restraint 77

6 Immunochemistry Market, Analysis by Country, Revenue ($m), 2004 - 2018 78

6.1 Immunochemistry Market, the US, Revenue ($m), Historic, 2004-2011 78

6.2 Immunochemistry Market, the US, Revenue ($m), Forecast, 2011-2018 79

6.3 Immunochemistry Market, Canada, Revenue ($m), Historic, 2004-2011 80

6.4 Immunochemistry Market, Canada, Revenue ($m), Forecast, 2011-2018 81

6.5 Immunochemistry Market, the UK, Revenue ($m), Historic, 2004-2011 82

6.6 Immunochemistry Market, the UK, Revenue ($m), Forecast, 2011-2018 83

6.7 Immunochemistry Market, Germany, Revenue ($m), Historic, 2004-2011 84

6.8 Immunochemistry Market, Germany, Revenue ($m), Forecast, 2011-2018 85

6.9 Immunochemistry Market, France, Revenue ($m), Historic, 2004-2011 86

6.10 Immunochemistry Market, France, Revenue ($m), Forecast, 2011-2018 87

6.11 Immunochemistry Market, Italy, Revenue ($m), Historic, 2004-2011 88

6.12 Immunochemistry Market, Italy, Revenue ($m), Forecast, 2011-2018 89

6.13 Immunochemistry Market, Spain, Revenue ($m), Historic, 2004-2011 90

6.14 Immunochemistry Market, Spain, Revenue ($m), Forecast, 2011-2018 91

6.15 Immunochemistry Market, Japan, Revenue ($m), Historic, 2004-2011 92

6.16 Immunochemistry Market, Japan, Revenue ($m), Forecast, 2011-2018 93

6.17 Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011 94

6.18 Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018 95

6.19 Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011 96

6.20 Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018 97

6.21 Immunochemistry Market, Australia, Revenue ($m), Historic, 2004-2011 98

6.22 Immunochemistry Market, Australia, Revenue ($m), Forecast, 2011-2018 99

6.23 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011 100

6.24 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018 101

7 Immunochemistry Market - Strategic Competitive Assessment 102

7.1 Immunochemistry, Key Market Participants 103

7.1.1 Siemens Healthcare Inc. 103

7.1.2 F. Hoffmann-La Roche Ltd. 109

7.1.3 Abbott Laboratories 114

8 Immunochemistry - Strategic Pipeline Assessment 119

9 Immunochemistry Market - Strategic Deals Analysis 121

9.1 High Number of Partnerships Characterizing the Deal Landscape 122

9.2 Investments by PE/VC Firms to Spur Innovation in Immunochemistry Market 122

9.3 Key Deals 122

9.3.1 Ventana Medical Enters into a Number of Companion Diagnostics Partnerships with Multiple Partners 122

9.3.2 Dako Enters into Co-development Agreement with Amgen 123

9.3.3 Sigma-Aldrich Completes Acquisition of BioReliance for $350m 123

9.3.4 Pronota Raises $4.8m in Series C Financing 124

9.3.5 Roche Enters into Joint Venture Agreement with Swiss Federal Institute of Technology, University of Zurich and University Hospital Zurich 124

9.3.6 Affymetrix to acquire eBioscience for $330m 124

10 Appendix 126

10.1 Market Definitions 126

10.1.1 Immunochemistry 126

10.2 Acronyms 129

10.3 Research Methodology 132

10.3.1 Secondary Research 132

10.3.2 Primary Research 132

10.3.3 Models 133

10.3.4 Forecasts 133

10.3.5 Expert Panels 133

10.3.6 GlobalData Consulting 133

10.3.7 Contact Us 134

10.3.8 Disclaimer 134

10.4 Sources 134

10.4.1 Corporate, Industry and Government Sources 134

10.4.2 Journals 136

10.4.3 Online Publications 136

10.4.4 Press Releases 137

List of Tables

Table 1: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 17

Table 2: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 18

Table 3: Companion Diagnostics in Immunochemistry 22

Table 4: Roche, Number of Companion Diagnostic Projects, 2006-2010 23

Table 5: Companion Diagnostics, Value Proposition Analysis 25

Table 6: Companion Diagnostics, Number of Partnerships, 2004-2010 26

Table 7: Number of Corporate Diagnostic Laboratory Chains, India, 2010 29

Table 8: Comparison of Various Finance Options 30

Table 9: Laboratory Acquisitions, the US, 2002-2008 33

Table 10: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011 35

Table 11: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018 36

Table 12: Percentage of Factors Contributing to Anemia Prevalence 37

Table 13: Correlation of Anemia and Economic Conditions 38

Table 14: Vitamin D Diagnosis, Product Approvals, 1999-2011 39

Table 15: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 41

Table 16: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 42

Table 17: Newly Discovered Tumor Markers, 2008-2011 43

Table 18: Principle of Action, Tumor Markers 44

Table 19: Prevalence Rate of Various Allergies, the US, 2001-2010 45

Table 20: Prevalence of Respiratory Symptoms and Risk Factors Among Children Aged between 6-11 Years, the UK, 2007-2008 46

Table 21: Prevalence of Autoimmune Diseases, Global, 2010 47

Table 22: Autoimmune Disease Research Funding, the US, 2005-2011 48

Table 23: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011 51

Table 24: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018 52

Table 25: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010 53

Table 26: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010 54

Table 27: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010 55

Table 28: Drug Tests, Olympics (Summer and Winter), 2000-2010 57

Table 29: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011 58

Table 30: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018 59

Table 31: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010 61

Table 32: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011 62

Table 33: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018 63

Table 34: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011 66

Table 35: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018 67

Table 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 69

Table 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 70

Table 38: Use of Immunoassay Detection Test, by Diagnosed Disease 71

Table 39: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 72

Table 40: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 73

Table 41: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 75

Table 42: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 76

Table 43: Immunochemistry Market, the US, Revenue ($m), 2004-2011 78

Table 44: Immunochemistry Market, the US, Revenue ($m), 2011-2018 79

Table 45: Immunochemistry Market, Canada, Revenue($m), 2004-2011 80

Table 46: Immunochemistry Market, Canada, Revenue ($m), 2011-2018 81

Table 47: Immunochemistry Market, the UK, Revenue ($m), 2004-2011 82

Table 48: Immunochemistry Market, the UK, Revenue ($'000), 2011-2018 83

Table 49: Immunochemistry Market, Germany, Revenue ($m), 2004-2011 84

Table 50: Immunochemistry Market, Germany, Revenue ($m), 2011-2018 85

Table 51: Immunochemistry Market, France, Revenue ($m), 2004-2011 86

Table 52: Immunochemistry Market, France, Revenue ($m), 2011-2018 87

Table 53: Immunochemistry Market, Italy, Revenue ($m), 2004-2011 88

Table 54: Immunochemistry Market, Italy, Revenue ($m), 2011-2018 89

Table 55: Immunochemistry Market, Spain, Revenue ($), 2004-2011 90

Table 56: Immunochemistry Market, Spain, Revenue ($m), 2011-2018 91

Table 57: Immunochemistry Market, Japan, Revenue ($m), 2004-2011 92

Table 58: Immunochemistry Market, Japan, Revenue ($'000), 2011-2018 93

Table 59: Immunochemistry Market, China, Revenue ($m), 2004-2011 94

Table 60: Immunochemistry Market, China, Revenue ($m), 2011-2018 95

Table 61: Immunochemistry Market, India, Revenue ($m), 2004-2011 96

Table 62: Immunochemistry Market, India, Revenue ($m), 2011-2018 97

Table 63: Immunochemistry Market, Australia, Revenue ($m), 2004-2011 98

Table 64: Immunochemistry Market, Australia, Revenue ($m), 2011-2018 99

Table 65: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 100

Table 66: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 101

Table 67: Immunochemistry Market, Global, Company Share (%), 2011 102

Table 68: Siemens Healthcare, Immunochemistry Portfolio*, 2011 103

Table 69: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment 104

Table 70: Siemens Healthcare, Emerging Markets Growth, 2008-2010 107

Table 71: F. Hoffmann-La Roche Ltd., Immunochemistry Portfolio*, 2011 109

Table 72: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment 110

Table 73: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010 113

Table 74: Abbott Laboratories, Immunochemistry Portfolio*, 2011 114

Table 75: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment 115

Table 76: Immunochemistry, Global Pipeline Products, 2011 119

Table 77: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011 120

Table 78: Immunochemistry Market, Deals, 2009-2011 121

List of Figures

Figure 1: Immunochemistry, Market Segmentation 10

Figure 2: Disease Specific Immunochemistry, Market Segmentation 11

Figure 3: Drugs of Abuse/Toxicology, Market Segmentation 13

Figure 4: Therapeutic Drug Monitoring, Market Segmentation 14

Figure 5: Endocrinology Tests, Market Segmentation 15

Figure 6: Immunochemistry Analyzers, Market Segmentation 16

Figure 7: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 17

Figure 8: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 18

Figure 9: Immunochemistry, Market Dynamics 22

Figure 10: Roche, Number of Companion Diagnostic Projects, 2006-2010 23

Figure 11: Companion Diagnostics, Value Proposition Analysis 24

Figure 12: Companion Diagnostics, Number of Partnerships, 2004-2010 26

Figure 13: Hub and Spoke Model used by Diagnostic Laboratories 29

Figure 14: Laboratory Acquisitions, the US, 2002-2008 32

Figure 15: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011 35

Figure 16: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018 36

Figure 17: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011 41

Figure 18: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018 42

Figure 19: Autoimmune Disease Research Funding, the US, 2005-2011 48

Figure 20: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011 51

Figure 21: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018 52

Figure 22: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010 53

Figure 23: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010 54

Figure 24: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010 55

Figure 25: Drug Tests, Olympics (Summer and Winter), 2000-2010 56

Figure 26: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011 58

Figure 27: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018 59

Figure 28: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010 61

Figure 29: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011 62

Figure 30: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018 63

Figure 31: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011 66

Figure 32: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018 67

Figure 33: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 69

Figure 34: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 70

Figure 35: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 72

Figure 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 73

Figure 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011 75

Figure 38: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018 76

Figure 39: Immunochemistry Market, the US, Revenue ($m), 2004-2011 78

Figure 40: Immunochemistry Market, the US, Revenue ($m), 2011-2018 79

Figure 41: Immunochemistry Market, Canada, Revenue($m), 2004-2011 80

Figure 42: Immunochemistry Market, Canada, Revenue ($m), 2011-2018 81

Figure 43: Immunochemistry Market, the UK, Revenue ($m), 2004-2011 82

Figure 44: Immunochemistry Market, the UK, Revenue ($m), 2011-2018 83

Figure 45: Immunochemistry Market, Germany, Revenue ($m), 2004-2011 84

Figure 46: Immunochemistry Market, Germany, Revenue ($m), 2011-2018 85

Figure 47: Immunochemistry Market, France, Revenue ($m), 2004-2011 86

Figure 48: Immunochemistry Market, France, Revenue ($m), 2011-2018 87

Figure 49: Immunochemistry Market, Italy, Revenue ($m), 2004-2011 88

Figure 50: Immunochemistry Market, Italy, Revenue ($m), 2011-2018 89

Figure 51: Immunochemistry Market, Spain, Revenue ($m), 2004-2011 90

Figure 52: Immunochemistry Market, Spain, Revenue ($m), 2011-2018 91

Figure 53: Immunochemistry Market, Japan, Revenue ($m), 2004-2011 92

Figure 54: Immunochemistry Market, Japan, Revenue ($m), 2011-2018 93

Figure 55: Immunochemistry Market, China, Revenue ($m), 2004-2011 94

Figure 56: Immunochemistry Market, China, Revenue ($m), 2011-2018 95

Figure 57: Immunochemistry Market, India, Revenue ($m), 2004-2011 96

Figure 58: Immunochemistry Market, India, Revenue ($m), 2011-2018 97

Figure 59: Immunochemistry Market, Australia, Revenue ($m), 2004-2011 98

Figure 60: Immunochemistry Market, Australia, Revenue ($m), 2011-2018 99

Figure 61: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 100

Figure 62: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 101

Figure 63: Immunochemistry Market, Global, Company Share (%), 2011 102

Figure 64: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment 104

Figure 65: Siemens Healthcare, SWOT Analysis, 2011 105

Figure 66: Siemens Healthcare, Revenue Share, by Region, 2010 106

Figure 67: Siemens Healthcare, Emerging Markets Growth, 2008-2010 106

Figure 68: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment 110

Figure 69: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011 111

Figure 70: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010 113

Figure 71: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment 115

Figure 72: Abbott Laboratories, SWOT Analysis, 2011 116

Figure 73: Immunochemistry, Global Pipeline Products, 2011 119

Figure 74: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011 120

Figure 75: Immunochemistry Market, Deals, 2009-2011 121

Companies mentioned

Siemens Healthcare Inc.

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

To order this report:

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker